StockData
Impact BioMedical Inc. logo

Impact BioMedical Inc. (IBO) stock

IBONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$3.06+0.38 (+14.18%)

Close on Oct 19, 2026Market cap $329.93MP/E –Yield –

Impact BioMedical pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Impact BioMedical's pe ratio was 33.0× on Oct 19, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 202633.0×+31.7
2025Jan 31, 20251.3×+0.2
2024Dec 31, 20241.1×–

More Impact BioMedical figures

See a number that looks wrong?